BLOEMFONTEIN – The Life Rosepark Hospital in Bloemfontein boasts new vascular hybrid theatre technology which is aligned with global advancement of healthcare. The hospital officially opened the new facility on Friday 23 January – marking a major step forward in healthcare for the region.
The first of its kind in Bloemfontein and central South Africa, the facility combines open surgery and minimally invasive endovascular procedures in one highly controlled environment. Designed with both patients and clinicians in mind, the theatre integrates cutting-edge technology and thoughtful design to deliver safer, more precise treatment options.
Delivering the keynote address, Prof. Asha Malan, presiding vascular surgeon at the hospital and the first female president of the Vascular Society of Southern Africa (Vassa), emphasised the theatre’s significance.
“This is far more than a new operating theatre – it is a step forward for healthcare in central South Africa. For too long, geography has dictated outcomes. Today, we say clearly and confidently that world-class vascular care belongs here, close to home.”
Hein Rossouw, hospital manager, highlighted the collaborative effort behind the project and its long-term impact.
“This theatre is not simply an upgrade to our facilities – it is an investment in the future of healthcare for the Free State. From the outset, our vision was to create a space where innovation, patient-centred care, and clinical excellence could come together,” he said.
“We are grateful to Life Healthcare for supporting a project that will change how vascular disease is treated in our region.”
At the heart of the theatre is the Philips Azerion FlexArm system, offering real-time imaging, reduced radiation exposure, and enhanced precision. This technology enables clinicians to tailor treatment with millimetre accuracy, particularly in complex cases involving the aorta, carotid arteries and visceral vessels.
The hybrid theatre also forms the foundation of the Free State Advanced Aortic Centre, a specialised initiative dedicated to treating complex aortic disease using minimally invasive techniques. Procedures that once required 10 to 12 hours of surgery can now be performed through small incisions, reducing risk and recovery time while aligning with international best practice.
The new theatre ensures safer care, faster recovery, and local access to advanced treatment –while providing referring doctors with a regional hub for clinical excellence and collaboration.
Malan believes the success of launching the new hybrid theatre is far-reaching.
“It marks the start of a new chapter in how we deliver vascular care in this region – one defined by precision, collaboration, and a relentless focus on what is best for the patient.”
Attendees at the official opening included private and public representatives, the hospital management, doctors and clinicians.
